Outcomes of Rituximab and Bendamustine Induction Regimen VS Cytarabine-Based Induction for Patients with Mantle Cell Lymphoma

被引：0
|
作者：
Alnimer, Yanal [1 ]
Yalniz, Fevzi [2 ]
Monohan, Gregory [2 ]
Munker, Reinhold [2 ]
Qasrawi, Ayman [3 ]
Iragavarapu, Chait [3 ]
Amr, Mahmoud [3 ]
机构：
[1] Univ Kentucky, Tappahannock, VA USA
[2] Univ Kentucky, Dept Hematol, Lexington, KY USA
[3] Univ Kentucky, Lexington, KY USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-211992
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6320 / 6321
页数：2
相关论文
共 50 条
  • [21] A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphoma
    Nobuhiko Nakamura
    Senji Kasahara
    Junichi Kitagawa
    Hiroshi Nakamura
    Michio Sawada
    Kenji Fukuno
    Yuhei Shibata
    Yuto Kaneda
    Takeshi Hara
    Nobuhiro Kanemura
    Hisashi Tsurumi
    Masahito Shimizu
    Experimental Hematology & Oncology, 11
  • [22] A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphoma
    Nakamura, Nobuhiko
    Kasahara, Senji
    Kitagawa, Junichi
    Nakamura, Hiroshi
    Sawada, Michio
    Fukuno, Kenji
    Shibata, Yuhei
    Kaneda, Yuto
    Hara, Takeshi
    Kanemura, Nobuhiro
    Tsurumi, Hisashi
    Shimizu, Masahito
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)
  • [23] Rituximab, Bendamustine and Cytarabine (RBAC500) As Induction Therapy in Elderly Patients with Mantle Cell Lymphoma: Final Results of a Phase 2 Study from the Fondazione Italiana Linfomi
    Visco, Carlo
    Chiappella, Annalisa
    Nassi, Luca
    Patti, Caterina
    Ferrero, Simone
    Barbero, Daniela
    Evangelista, Andrea
    Spina, Michele
    Molinari, Anna Lia
    Rigacci, Luigi
    Tani, Monica
    Di Rocco, Alice
    Pinotti, Graziella
    Fabbri, Alberto
    Zambello, Renato
    Finotto, Silvia
    Gotti, Manuel
    Carella, Angelo Michele
    Salvi, Flavia
    Pileri, Stefano A.
    Ladetto, Marco
    Ciccone, Giovannino
    Gaidano, Gianluca
    Ruggeri, Marco
    Martelli, Maurizio
    Vitolo, Umberto
    BLOOD, 2016, 128 (22)
  • [24] Bendamustine, Obinutuzumab and Venetoclax As Induction Therapy for Untreated Mantle Cell Lymphoma
    Greenwell, Irl Brian
    Switchenko, Jeffrey M.
    Maddocks, Kami J.
    Kahl, Brad S.
    Craig, Alexander F. M.
    Alizadeh, Ash A.
    Allen, Pamela B.
    Marbury, Alena Lorretta
    Escobar, Alicia
    Valla, Kelly
    Williams, Miayea
    Parikh, Priya
    Roberts, Danielle
    Neely, Jessica J.
    Palmer, Alexandra
    Blum, Kristie A.
    Cohen, Jonathon B.
    BLOOD, 2020, 136
  • [25] A Pilot Study of Acalabrutinib with Bendamustine/Rituximab Followed By Cytarabine/Rituximab (R-ABC) for Untreated Mantle Cell Lymphoma
    Guy, Daniel
    Watkins, Marcus
    Wan, Fei
    Bartlett, Nancy L.
    Cashen, Amanda F.
    Fehniger, Todd A.
    Ghobadi, Armin
    Mehta-Shah, Neha
    Kahl, Brad S.
    BLOOD, 2020, 136
  • [26] Modified VR-CAP, Alternating With Rituximab and High-dose Cytarabine: An Effective Pre-transplant Induction Regimen for Mantle Cell Lymphoma
    Smith, Stephen D.
    Gandhy, Shruti
    Gopal, Ajay K.
    Reddy, Prathima
    Shadman, Mazyar
    Till, Brian G.
    Lynch, Ryan C.
    Kanan, Sandra
    Cowan, Andrew
    Low, Lauren
    Hill, Brian T.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (01) : 48 - 52
  • [27] RITUXIMAB, BENDAMUSTINE, AND CYTARABINE (R-BAC) COMPARED WITH RITUXIMAB AND BENDAMUSTINE (BR) IN PREVIOUSLY UNTREATED ELDERLY PATIENTS WITH MANTLE CELL LYMPHOMA (BE-VE-BAC STUDY)
    Bega, G.
    Olivieri, J.
    Riva, M.
    Scapinello, G.
    Paolini, R.
    Finotto, S.
    Sartori, R.
    Lucchini, E.
    Guandalini, G.
    Facchinelli, D.
    Tisi, M. C.
    Basso, M.
    Ballotta, L.
    Piazza, F.
    Ferrarini, I.
    Visco, C.
    HAEMATOLOGICA, 2021, 106 (10) : 67 - 68
  • [28] Rituximab/Bendamustine and Rituximab/Cytarabine (RB/RC) Induction Chemotherapy for Transplant-Eligible Patients with Mantle Cell Lymphoma: A Pooled Analysis of Two Phase 2 Clinical Trials and Off-Trial Experience
    Merryman, Reid W.
    Kahl, Brad S.
    Redd, Robert A.
    Bsat, Jad
    Chase, Matthew Lewis
    LaCasce, Ann S.
    Freedman, Arnold S.
    Jacobson, Caron A.
    Fisher, David C.
    Ng, Samuel Y.
    Crombie, Jennifer L.
    Kim, Austin I.
    Odejide, Oreofe O.
    Davids, Matthew S.
    Brown, Jennifer R.
    Jacene, Heather A.
    Neha, Mehta-Shah
    Edwin, Natasha
    Cashen, Amanda F.
    Bartlett, Nancy L.
    Ghobadi, Armin
    Armand, Philippe
    Joyce, Robin M.
    Jacobsen, Eric D.
    BLOOD, 2018, 132
  • [29] Outcomes after autologous stem cell transplantation for mantle cell lymphoma based on remission status and induction chemotherapy regimen
    Till, Brian G.
    Gooley, Theodore A.
    Crawford, Nathan
    Gopal, Ajay K.
    Maloney, David G.
    Petersdorf, Stephen H.
    Pagel, John M.
    Holmberg, Leona
    Bensinger, William
    Press, Oliver W.
    BLOOD, 2007, 110 (11) : 566A - 566A
  • [30] Rituximab, Bendamustine and Cytarabine Followed By Venetoclax (V-RBAC) in High-Risk Elderly Patients with Mantle Cell Lymphoma
    Visco, Carlo
    Tabanelli, Valentina
    Peracchio, Claudia
    Evangelista, Andrea
    Tisi, Maria Chiara
    Merli, Anna
    Fraenza, Costanza
    Fiori, Stefano
    Re, Alessandro
    Castellino, Claudia
    Zilioli, Vittorio Ruggero
    Piazza, Francesco
    Corradini, Paolo
    Hohaus, Stefan
    Musuraca, Gerardo
    Ferla, Valeria
    Puccini, Benedetta
    Cavallo, Federica
    Ballerini, Filippo
    Sciarra, Roberta
    Di Rocco, Alice
    Arcari, Annalisa
    Boccomini, Carola
    Merli, Francesco
    Gini, Guido
    Tani, Monica
    Bruna, Riccardo
    Pavone, Vincenzo
    Ferreri, Andres J. M.
    Santoro, Armando
    Patti, Caterina
    Loseto, Giacomo
    Ladetto, Marco
    Merli, Michele
    Spina, Michele
    Zinzani, Pier Luigi
    Stefani, Pietro Maria
    Usai, Sara Veronica
    Stelitano, Caterina
    Volpetti, Stefano
    Pileri, Stefano A.
    Balzarotti, Monica
    BLOOD, 2021, 138
12345